Ultratech Diagnostics Centre Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 29-12-2024
- Paid Up Capital ₹ 3.65 M
as on 29-12-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.94 M
as on 29-12-2024
- Revenue -3.72%
(FY 2020)
- Profit -94.86%
(FY 2020)
- Ebitda 5.36%
(FY 2020)
- Net Worth 0.23%
(FY 2020)
- Total Assets 35.68%
(FY 2020)
About Ultratech Diagnostics Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.65 M.
The company currently has active open charges totaling ₹3.94 M.
Rajnish Labh, Pramod Kumar, and Kali Rajak serve as directors at the Company.
- CIN/LLPIN
U85195BR2008PTC013822
- Company No.
013822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ultratech Diagnostics Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Kumar  | Managing Director | 05-Aug-2008 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajnish Labh | Director | 05-Aug-2008 | Current |
| Kali Rajak | Director | 29-Jul-2022 | Current |
Financial Performance of Ultratech Diagnostics Centre.
Ultratech Diagnostics Centre Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.72% decrease. The company also saw a substantial fall in profitability, with a 94.86% decrease in profit. The company's net worth moved up by a moderate rise of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultratech Diagnostics Centre?
In 2017, Ultratech Diagnostics Centre had a promoter holding of 63.72% and a public holding of 36.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.94 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.39 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2008 | Syndicate Bank | ₹3.94 M | Open |
How Many Employees Work at Ultratech Diagnostics Centre?
Unlock and access historical data on people associated with Ultratech Diagnostics Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultratech Diagnostics Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultratech Diagnostics Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
